Patient involvement in the JCA
Site: | EUPATI Open Classroom |
Course: | EU Health Technology Assessment Regulation (HTAR) |
Book: | Patient involvement in the JCA |
Printed by: | Guest user |
Date: | Sunday, 11 May 2025, 2:21 PM |
1. Why are patients involved in the JCA?
Patient organisations who are represented in the Stakeholder Network may be asked to advise and help identify potential patient experts who have HTA and scientific knowledge. Patients can provide insights as individual patients into their own experiences, needs and perspectives or into the multiple experiences, needs and perspectives of the patient group they represent.
2. How are patients involved in Joint Clinical Assessment (what is the mechanism)?
Patients can be involved in the JCA process by providing input and insights on patient relevant outcomes, experiences, and preferences.
Article 25 of the regulation says:
‘The Commission shall adopt, after consulting all relevant stakeholders, by means of implementing acts, general procedural rules: ensuring that the members of the Coordination Group, its subgroups, as well as patients, clinical experts and other relevant experts take part in joint clinical assessments in an independent and transparent manner, free from conflict of interest on the selection and consultation of stakeholder organisations and patients, clinical experts and other relevant experts in joint clinical assessments at Union level.’